
GR Cheminn Pharma Private Limited
About GR Cheminn Pharma Private Limited
Data last updated:
GR Cheminn Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2000PTC035598.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Zia Ansari and Farah Raju Gokaraju.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No. 3 – 6 – 190 Lb Nagar, Hyderabad, Telangana, India – 500074.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.94 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹22.3 Lakh (net margin 49.6%) and EBITDA of ₹32.74 Lakh (EBITDA margin 72.9%). Revenue has grown at a compounded annual rate (CAGR) of 280% over three years and 142% over five years.
As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
GR Cheminn Pharma has one previous CIN (Corporate Identification Number): U24231AP2000PTC035598. The current CIN is U24231TG2000PTC035598, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2000PTC035598 | Current |
| U24231AP2000PTC035598 | Previous |
Contact details
GR Cheminn Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDoor No. 3 – 6 – 190 Lb Nagar, Hyderabad, Telangana, India – 500074
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of GR Cheminn Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of GR Cheminn Pharma Private Limited
FY 2025 filings availableGR Cheminn Pharma Private Limited reported revenue of ₹44.94 Lakh (up 212% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 142% over five years, including 212% growth in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 72.9% | ||||
| Net Profit Margin | 49.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GR Cheminn Pharma Private Limited, buy the company report.
Board of directors of GR Cheminn Pharma Private Limited
GR Cheminn Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Zia Ansari Also directs: Sudershan Laboratories Limited, GR Intrachem Limited, Imperial Projects India Private Limited and 2 more | Director | 26 Feb 2021 | 5 Years 8 Months | Current |
| Farah Raju Gokaraju Also directs: Sudershan Laboratories Limited, GR Intrachem Limited, Imperial Projects India Private Limited and 4 more | Director | 29 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
GR Cheminn Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tissot Pharmaceutical Private Limited | ₹45.08 Lakh (FY 2025) | 173.0% | Hyderabad, Telangana, India | |||
| Glester Pharmaceuticals Private Limited | ₹45.01 Lakh (FY 2024) | -3.0% | Ahmedabad, Gujarat, India | |||
| Nutrocrats Private Limited | ₹44.97 Lakh (FY 2025) | -52.0% | Datia, Madhya Pradesh, India | |||
| Aishinova Pharma Private Limited | ₹44.95 Lakh (FY 2024) | 14.0% | Pune, Maharashtra, India | |||
| Heypharma Wellness Private Limited | ₹44.94 Lakh (FY 2025) | 19.0% | Kolkata, West Bengal, India | |||
| GR Cheminn Pharma Private Limitedthis company | ₹44.94 Lakh (FY 2025) | ₹22.3 Lakh | 49.6% | 212.0% | Hyderabad, Telangana, India | |
| Anthro Pharmaceuticals Private Limited | ₹44.84 Lakh (FY 2024) | 7.0% | Navi Mumbai, Maharashtra, India | |||
| Zeeks Lifesciences Private Limited | ₹44.81 Lakh (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Langelie Biologicals Pharma Private Limited | ₹44.72 Lakh (FY 2024) | -19.0% | Patna, Bihar, India | |||
| Golden Streak Laboratories Limited | ₹44.68 Lakh (FY 2025) | 142.0% | Telangana, India | |||
| Sterllink Display Private Limited | ₹44.66 Lakh (FY 2025) | 72.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of GR Cheminn Pharma Private Limited, buy the company report.
Auditor
GR Cheminn Pharma Private Limited is audited by CSNR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CSNR & ASSOCIATES | FY 2023 | 021316S |
Shareholding
The shareholding of GR Cheminn Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GR Cheminn Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2006 | 10014987 | Uco Bank | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
GR Cheminn Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed against the company | Pending |
To see the full case history of GR Cheminn Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GR Cheminn Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for GR Cheminn Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
GR Cheminn Pharma Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Farah Raju Gokaraju ceased to be Additional Director on 11 Nov 2021.
Frequently asked questions
GR Cheminn Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 November 2000 (26+ years old) and is registered under CIN U24231TG2000PTC035598.
GR Cheminn Pharma has 2 current directors:
- Zia Ansari - Director
- Farah Raju Gokaraju - Director
The latest financial statements of GR Cheminn Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of GR Cheminn Pharma is U24231TG2000PTC035598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GR Cheminn Pharma has 1 court case on record: 1 filed against it. 1 is pending.
GR Cheminn Pharma was incorporated on 03 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of GR Cheminn Pharma by revenue are Tissot Pharmaceutical Private Limited, Glester Pharmaceuticals Private Limited, Nutrocrats Private Limited, Aishinova Pharma Private Limited, Heypharma Wellness Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Farah Raju Gokaraju ceased to be Additional Director on 11 Nov 2021. Zia Ansari ceased to be Additional Director on 11 Nov 2021. Zia Ansari was appointed as Director on 26 Feb 2021. GR Cheminn Pharma has 7 board changes on record in total.
The registered office of GR Cheminn Pharma is at Door No. 3 – 6 – 190 Lb Nagar, Hyderabad, Telangana, India – 500074.
GR Cheminn Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
GR Cheminn Pharma has open charges of ₹2 Cr and no satisfied charges on record as per latest MCA filings.

